Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NF1 × mirdametinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

NF1 1 Multiple Myeloma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06159166 2025-04-23

Mirda

Johns Hopkins University

Phase 1/2 Recruiting

CNSDermatologic

NF1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡